Skip to main content

Table 2 Organ absorbed doses

From: Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteers

Organ

Absorbed dose (μGy/MBq)

Adrenals

4.6 ± 0.9

Brain

4.0 ± 0.3

Breasts

2.2 ± 0.0

Gallbladder wall

5.4 ± 0.4

Heart wall

12.8 ± 0.5

Kidneys

21.0 ± 0.5

Liver

8.3 ± 0.9

Lower large intestine wall

2.3 ± 0.1

Lungs

16.8 ± 2.7

Muscle

2.2 ± 0.1

Osteogenic cells

3.6 ± 0.1

Ovaries

2.5 ± 0.1

Pancreas

16.5 ± 2.2

Red marrow

3.2 ± 0.1

Skin

1.7 ± 0.1

Small intestine

5.4 ± 0.9

Spleen

16.6 ± 6.6

Stomach wall

4.5 ± 0.9

Testes

3.6 ± 0.7

Thymus

2.1 ± 0.0

Thyroid

12.0 ± 3.9

Upper large intestine wall

2.8 ± 0.1

Urinary bladder wall

2.1 ± 0.1

Uterus

2.5 ± 0.1

Total body

2.8 ± 0.0

Effective dose (μSv/MBq)

5.9 ± 0.6

  1. Data are the mean ± SD for healthy male subjects (n = 3)